CMEC 22nd meeting, 25 August 2000
Complementary Medicines Evaluation Committee
Extracted ratified minutes
CMEC Meeting 22 extracted ratified minutes (pdf,30kb)
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
Item 2 Confirmation of draft minutes of CMEC 21
Recommendation 22.1
CMEC confirms that the draft Minutes of its previous meeting (CMEC 21) as amended at the present meeting be considered a true and accurate record of that previous meeting.
Item 5.1 Action arising from previous meeting - Phenylalanine
Recommendation 22.2
That the suitability of L-phenylalanine as an active ingredient in listable therapeutic goods is confirmed subject to a labelling warning "Do not use if pregnant or likely to become pregnant" where the recommended daily dose exceeds 500mg.
Item 6.1 Santalum spicatum
Recommendation 22.3
That Santalum spicatum oil is suitable for use in listable therapeutic goods for topical or inhalational use but not oral use.
Item 6.2 Backhousia citriodora
Recommendation 22.4
That Backhousia citriodora leaf oil at a concentration not exceeding 1% (w/w) is suitable for use in listable therapeutic goods for topical use.
Item 10.6 Consideration of reports from the Adverse Drug Reactions Advisory Committee
Recommendation 22.5
That CMEC would provide comment to the Adverse Drug Reactions Advisory Committee (ADRAC) on reports from the ADRAC.